Page last updated: 2024-08-25

methotrexate and misoprostol

methotrexate has been researched along with misoprostol in 116 studies

Research

Studies (116)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	57 (49.14)	18.2507
2000's	43 (37.07)	29.6817
2010's	12 (10.34)	24.3611
2020's	4 (3.45)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Creinin, MD; Galbraith, S; Klaisle, C; Vittinghoff, E	1
Creinin, MD; Vittinghoff, E	1
Rutter, TL	1
Hausknecht, RU	1
Eisinger, SH; Franks, P; Kim, SS; Schaff, EA	2
Potts, M	1
Creinin, MD	7
Wiebe, ER	10
Kerigan, AT	1
Creinin, MD; Darney, PD	1
Creinin, MD; Park, M	1
Hoffman, RS; Perrone, J	1
Niebyl, JR; Yankowitz, J	1
Grunberg, SM	1
Swanson, KT	1
Basinski, AS; Ferris, LE	1
Wolff, F	1
Eisinger, SH; Franks, P; Schaff, EA; Wortman, M	1
Lauber, JJ	1
Lichtenhan, JB	1
Camosy, PA	1
Creinin, MD; Darney, PD; Keder, L; Tiller, G; Vittinghoff, E	1
Burke, AE; Creinin, MD	1
Abbasciano, V; Nielsen, I; Sartori, S; Tassinari, D; Trevisani, L	1
Eisinger, SH; Franks, P; Penmetsa, U; Schaff, EA	1
Anderson, MR; Gold, M; Luks, D	1
Arslan, A; Corakçi, A; Erhan, G; Mercan, R; Ozeren, S; Yücesoy, I	1
Creinin, MD; Shulman, T	1
Cabezas, E; Carbonell I Esteve, JL; Fernández, C; Sánchez, C; Varela, L; Velazco, A	1
Creinin, MD; Darney, PD; Dean, C; Klaisle, C; Schaff, E; Vittinghoff, E	1
Creinin, MD; Krohn, MA	1
Cabezas, E; Carbonell, JL; Fernández, C; Sánchez, C; Varela, L; Velazco, A	1
Ewart, WR; Winikoff, B	1
Creinin, MD; DeLoia, JA; Stewart-Akers, AM	1
Barley, G; O'Brien-Gonzales, A; Westfall, JM	1
Creinin, MD; Jerald, H	1
Carbonell Esteve, JL; Sánchez, C; Tanda, R; Varela, L; Velazco, A	1
Creinin, MD; Gold, M; Wiebe, E	1
Carbonell, JL; Creinin, MD; Schwartz, JL; Tanda, R; Varela, L	1
Paul, M	1
Hanssens, M; Moerman, P; Page, G; Van Assche, A; Van Den Berghe, K; Vandeginste, S; Vergote, IB	1
Aydemir, V; Bilekli, C; Bozkaya, H; Ozeren, M	1
Autry, A; Isbill, K; Jacobson, G; Sandhu, R	1
Creinin, MD; Pymar, HC	1
von Hertzen, H	1
Borgatta, L; Burnhill, M; Haskell, S; Leonhardt, K; Nichols, M	1
Switzer, P; Wiebe, ER	1
Nemecek, S	1
Darney, PD; Goldberg, AB; Greenberg, MB	1
Borgatta, L; Burnhill, MS; Haskell, S; Hausknecht, RU; Leonhardt, KK; Tyson, J	1
Elahi, EH	1
Borgatta, L; Burnhill, MS; French, A; Vragovic, O	1
Nathanson, BN	1
Kleinman, G; Rosenman, S	1
Dunn, S; Guilbert, E; Jacot, F; Lugtig, L; Wiebe, E	1
O'Meara, P; Stanford, M; Wheeler, M	1
Bygdeman, M; Danielsson, KG	1
Creinin, MD; Holovanisin, M; Janczukiewicz, L; Meyn, L; Potter, C; Pymar, HC; Schwartz, JL	1
Creinin, MD; Murthy, A	1
Lichtenberg, ES	1
Agrawal, V; Gautam, R	1
Adam, MP; Beck, AE; Clericuzio, C; Enns, GM; Hoyme, HE; Kwan, A; Manning, MA	1
Campana, A; Cheng, LN; Gülmezoglu, AM; Hofmeyr, GJ; Kulier, R	2
Creinin, MD; Grimes, DA	1
Nothnagle, M; Taylor, JS	1
Trouton, K; Wiebe, ER	1
Flett, GM; Hamoda, H	1
Ioannidis, JP; Makrydimas, G; Papatheodorou, S; Sotiriadis, A	1
Morgan, FC; Whitecar, PW; Yedlinsky, NT	1
Amaliev, I; Iamakov, K; Pekhlivanov, B	1
Dahiya, K; Hooda, R; Khosla, AH; Madan, S; Sangwan, K	1
Deutsch, R; Moran, T	1
Diaz-Olavarrieta, C; Foster, AM; Rouhana, A; Schaffer, K; Trussell, J; Wynn, L	1
Lima, R; Trouton, KJ; Wiebe, ER	1
Bobby, P; Cole, DS; Garry, DJ; Goffman, D	1
Aldrich, T; Winikoff, B	1
Li, Q; Liu, M; Mu, YL; Yang, ZL; Yin, FB	1
Hempstock, W; Wiebe, E	1
Boersma, AA; Meyboom-de Jong, B	1
Behnamfar, F; Mousavi, SA	1
Deutchman, M; Tubay, AT; Turok, D	1
Böttcher, A; Guder, E; Just, T	1
Kozma, C; Ramasethu, J	1
Belmont-Gómez, A; Carvajal-Valencia, JA; Chacón-Solís, RA; Estrada-Altamirano, A; Hernández-Pacheco, JA; Maya-Quiñones, JL; Valenzuela-Jirón, A	1
Campana, A; Cheng, L; Gülmezoglu, AM; Hofmeyr, GJ; Kapp, N; Kulier, R	1
Khan, ZA; Mishra, B; Tripathi, R	1
Adevai, T; Jensen, J; Martin, L; Micks, E; Riefenberg, S; Shekell, T; Stanley, J; Zelinski, M	1
MacDonald, K; Norman, WV; Popescu, O	1
Chernev, A; Chernev, T; Manueljan, M	1
Dunn, S; Feuerstein, E; Gupta, M; Meaney, C; Morgan, R; Panjwani, D	1
Elhage, W; Holtsema, H; Manshande, ME; van Haelst, MM; Verberne, EA; Wagner-Buitenweg, NF	1
Lieu, H; Maslowski, K; Scheck, S; Sircar, S	1
Mazer-Amirshahi, M; Ye, P	1
Barkemeyer, AK; Barkemeyer, BM; Gupta, RW; Joslyn, PW	1

Reviews

16 review(s) available for methotrexate and misoprostol

Article	Year
Medical options for early pregnancy termination. American family physician, 1997, Volume: 56, Issue:2 Topics: Abortifacient Agents; Abortion, Induced; Algorithms; Decision Trees; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Time Factors; Treatment Outcome	1997
Success rates and estimation of gestational age for medical abortion vary with transvaginal ultrasonographic criteria. American journal of obstetrics and gynecology, 1999, Volume: 180, Issue:1 Pt 1 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Gestational Age; Humans; Methotrexate; Misoprostol; Obstetrics; Pregnancy; Retrospective Studies; Treatment Outcome; Ultrasonography	1999
Office management of early induced abortion. Clinical obstetrics and gynecology, 1999, Volume: 42, Issue:2 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Ambulatory Care; Female; Humans; Methotrexate; Misoprostol; Office Visits; Postoperative Care; Postoperative Complications; Pregnancy; Pregnancy Trimester, First	1999
Misoprostol and pregnancy. The New England journal of medicine, 2001, Jan-04, Volume: 344, Issue:1 Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Abortion, Missed; Cervical Ripening; Drug Therapy, Combination; Empirical Research; Female; Government Regulation; Humans; Labor, Induced; Methotrexate; Mifepristone; Misoprostol; Mobius Syndrome; Oxytocics; Postpartum Hemorrhage; Pregnancy; Pregnant Women	2001
Options for early therapeutic abortion: a comparative review. Drugs, 2002, Volume: 62, Issue:17 Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Alprostadil; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Pregnancy, Ectopic; Randomized Controlled Trials as Topic; Treatment Outcome; Vacuum Curettage	2002
Pharmacoeconomics of medical abortion: a review of cost in the United States, Europe and Asia. Expert opinion on pharmacotherapy, 2003, Volume: 4, Issue:4 Topics: Abortion, Induced; Adolescent; Adult; Asia; Costs and Cost Analysis; Economics, Pharmaceutical; Europe; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; United States	2003
Methotrexate/misoprostol embryopathy: report of four cases resulting from failed medical abortion. American journal of medical genetics. Part A, 2003, Nov-15, Volume: 123A, Issue:1 Topics: Abnormalities, Multiple; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Infant; Male; Methotrexate; Misoprostol; Pregnancy; Pregnancy, Ectopic	2003
Medical methods for first trimester abortion. The Cochrane database of systematic reviews, 2004, Issue:1 Topics: Abortifacient Agents; Abortion, Incomplete; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Tamoxifen	2004
Induced abortion: an overview for internists. Annals of internal medicine, 2004, Apr-20, Volume: 140, Issue:8 Topics: Abortifacient Agents; Abortion, Induced; Adult; Costs and Cost Analysis; Female; Humans; Internal Medicine; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Referral and Consultation; Socioeconomic Factors; United States	2004
Medical methods for first trimester abortion. The Cochrane database of systematic reviews, 2004, Issue:2 Topics: Abortifacient Agents; Abortion, Incomplete; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Randomized Controlled Trials as Topic; Tamoxifen	2004
Medical methods for first-trimester abortion. American family physician, 2004, Jul-01, Volume: 70, Issue:1 Topics: Abortifacient Agents; Abortion, Induced; Alprostadil; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Tamoxifen; Treatment Outcome	2004
Medical termination of pregnancy in the early first trimester. The journal of family planning and reproductive health care, 2005, Volume: 31, Issue:1 Topics: Abortifacient Agents; Abortion, Induced; Antimetabolites; Dilatation and Curettage; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins	2005
Expectant, medical, or surgical management of first-trimester miscarriage: a meta-analysis. Obstetrics and gynecology, 2005, Volume: 105, Issue:5 Pt 1 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Incomplete; Abortion, Missed; Abortion, Spontaneous; Adolescent; Adult; Dilatation and Curettage; Female; Follow-Up Studies; Humans; Methotrexate; Misoprostol; Pregnancy; Pregnancy Trimester, First; Risk Assessment; Treatment Outcome; Vacuum Curettage	2005
Medical methods for first trimester abortion. The Cochrane database of systematic reviews, 2011, Nov-09, Issue:11 Topics: Abortifacient Agents; Abortion, Incomplete; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Randomized Controlled Trials as Topic; Tamoxifen	2011
Methotrexate: a detailed review on drug delivery and clinical aspects. Expert opinion on drug delivery, 2012, Volume: 9, Issue:2 Topics: Abortion, Induced; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiparasitic Agents; Biological Availability; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Administration Routes; Drug Combinations; Drug Delivery Systems; Drug Interactions; Drug Therapy, Combination; Female; Humans; Liposomes; Methotrexate; Misoprostol; Nanoparticles; Pregnancy; Prodrugs	2012
Toxicity of abortifacients: A review for physicians in the post roe era. The American journal of emergency medicine, 2022, Volume: 61 Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Physicians; Pregnancy; United States	2022

Trials

36 trial(s) available for methotrexate and misoprostol

Article	Year
A randomized trial comparing misoprostol three and seven days after methotrexate for early abortion. American journal of obstetrics and gynecology, 1995, Volume: 173, Issue:5 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Adult; Age Factors; Drug Administration Schedule; Female; Gestational Age; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Parity; Pregnancy; Pregnancy Trimester, First	1995
Methotrexate and misoprostol vs misoprostol alone for early abortion. A randomized controlled trial. JAMA, 1994, Oct-19, Volume: 272, Issue:15 Topics: Abortion, Induced; Administration, Intravaginal; Adult; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Peptide Fragments; Pregnancy	1994
Combined methotrexate and misoprostol for early induced abortion. Archives of family medicine, 1995, Volume: 4, Issue:9 Topics: Abortion, Induced; Adult; Chorionic Gonadotropin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Methotrexate; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Treatment Outcome	1995
Methotrexate and misoprostol for abortion at 57-63 days gestation. Contraception, 1994, Volume: 50, Issue:6 Topics: Abortion, Induced; Acetaminophen; Administration, Oral; Adult; Chorionic Gonadotropin; Codeine; Colic; Drug Therapy, Combination; Female; Humans; Ibuprofen; Injections, Intramuscular; Methotrexate; Mifepristone; Misoprostol; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Time Factors	1994
Acceptability of medical abortion with methotrexate and misoprostol. Contraception, 1995, Volume: 52, Issue:1 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Methotrexate; Misoprostol; Patient Acceptance of Health Care; Pregnancy; Prospective Studies; Surveys and Questionnaires	1995
Change in serum beta-human chorionic gonadotropin after abortion with methotrexate and misoprostol. American journal of obstetrics and gynecology, 1996, Volume: 174, Issue:2 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Pregnancy	1996
Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy. Contraception, 1996, Volume: 53, Issue:6 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Adult; Chorionic Gonadotropin; Female; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Odds Ratio; Parity; Patient Compliance; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Prospective Studies; Safety; Surveys and Questionnaires	1996
Oral methotrexate and vaginal misoprostol for early abortion. Contraception, 1996, Volume: 54, Issue:1 Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Female; Humans; Methotrexate; Misoprostol; Pregnancy; Prospective Studies	1996
Methotrexate and misoprostol for early abortion: a multicenter trial. Acceptability. Contraception, 1996, Volume: 54, Issue:1 Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Attitude; Female; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Patient Satisfaction; Pregnancy; Prospective Studies; Surveys and Questionnaires	1996
Misoprostol and omeprazole in the prevention of chemotherapy-induced acute gastroduodenal mucosal injury. A randomized, placebo-controlled pilot study. Cancer, 1996, Oct-01, Volume: 78, Issue:7 Topics: Adult; Aged; Anti-Ulcer Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Gastric Acid; Gastric Mucosa; Humans; Male; Methotrexate; Middle Aged; Misoprostol; Omeprazole; Peptic Ulcer; Pilot Projects	1996
Methotrexate and misoprostol for early abortion. Family medicine, 1996, Volume: 28, Issue:3 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Legal; Adolescent; Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Methotrexate; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Treatment Outcome	1996
Methotrexate. A single agent for early abortion. The Journal of reproductive medicine, 1997, Volume: 42, Issue:1 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Drug Therapy, Combination; Ethnicity; Female; Humans; Methotrexate; Middle Aged; Misoprostol; Patient Selection; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Prospective Studies	1997
Abortion induced with methotrexate and misoprostol: a comparison of various protocols. Contraception, 1997, Volume: 55, Issue:3 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Canada; Cohort Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Patient Acceptance of Health Care; Pregnancy; Pregnancy Trimester, First; Time Factors; Urban Population	1997
Efficacy of methotrexate and misoprostol for early abortion. Gynecologic and obstetric investigation, 1997, Volume: 44, Issue:2 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Adult; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Pregnancy; Prospective Studies	1997
Misoprostol 3, 4, or 5 days after methotrexate for early abortion. A randomized trial. Contraception, 1997, Volume: 56, Issue:3 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Female; Humans; Methotrexate; Misoprostol; Pregnancy; Pregnancy Trimester, First	1997
Medical abortion with oral methotrexate and vaginal misoprostol. Obstetrics and gynecology, 1997, Volume: 90, Issue:4 Pt 1 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Confidence Intervals; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Methotrexate; Misoprostol; Multivariate Analysis; Prospective Studies; Regression Analysis	1997
Methotrexate pharmacokinetics and effects in women receiving methotrexate 50 mg and 60 mg per square meter for early abortion. American journal of obstetrics and gynecology, 1997, Volume: 177, Issue:6 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Pregnancy	1997
Medical abortion with methotrexate 75 mg intramuscularly and vaginal misoprostol. Contraception, 1997, Volume: 56, Issue:6 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Adult; Drug Therapy, Combination; Female; Folic Acid Antagonists; Follow-Up Studies; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Prospective Studies; Time Factors; Treatment Outcome	1997
Oral methotrexate and vaginal misoprostol for early abortion. Contraception, 1998, Volume: 57, Issue:2 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Female; Gestational Age; Humans; Methotrexate; Misoprostol; Pregnancy; Prospective Studies; Treatment Outcome	1998
Methotrexate effects on trophoblast and the corpus luteum in early pregnancy. American journal of obstetrics and gynecology, 1998, Volume: 179, Issue:3 Pt 1 Topics: 17-alpha-Hydroxyprogesterone; Abortifacient Agents; Adult; Chorionic Gonadotropin, beta Subunit, Human; Corpus Luteum; Female; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Pregnancy; Pregnancy Trimester, First; Progesterone; Prospective Studies; Trophoblasts	1998
25 mg or 50 mg of oral methotrexate followed by vaginal misoprostol 7 days after for early abortion: a randomized trial. Gynecologic and obstetric investigation, 1999, Volume: 47, Issue:3 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Female; Humans; Methotrexate; Misoprostol; Pregnancy; Time Factors; Treatment Outcome	1999
Methotrexate and misoprostol for early abortion in adolescent women. Journal of pediatric and adolescent gynecology, 1999, Volume: 12, Issue:2 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Adolescent; Algorithms; Decision Trees; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Patient Acceptance of Health Care; Pregnancy; Prospective Studies; Surveys and Questionnaires	1999
Comparing abortion induced with methotrexate and misoprostol to methotrexate alone. Contraception, 1999, Volume: 59, Issue:1 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Adult; Cohort Studies; Drug Therapy, Combination; Female; Gestational Age; Humans; Methotrexate; Misoprostol; Pain Measurement; Patient Satisfaction; Pregnancy; Pregnancy Outcome; Ultrasonography; Uterus	1999
A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortion. Contraception, 1999, Volume: 59, Issue:1 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Adult; Female; Gestational Age; Humans; Methotrexate; Misoprostol; Pregnancy; Pregnancy Outcome; Ultrasonography; Uterus; Water	1999
Oral methotrexate compared with injected methotrexate when used with misoprostol for abortion. American journal of obstetrics and gynecology, 1999, Volume: 181, Issue:1 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Adult; Female; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Pregnancy; Treatment Outcome	1999
Tamoxifen compared to methotrexate when used with misoprostol for abortion. Contraception, 1999, Volume: 59, Issue:4 Topics: Abortion, Incomplete; Abortion, Induced; Administration, Intravaginal; Adult; Female; Gestational Age; Humans; Methotrexate; Misoprostol; Patient Satisfaction; Pregnancy; Tamoxifen; Treatment Outcome	1999
Methotrexate and misoprostol used alone or in combination for early abortion. Contraception, 1999, Volume: 59, Issue:6 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Incomplete; Abortion, Induced; Administration, Intravaginal; Adult; Chorionic Gonadotropin; Female; Gestational Age; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Pregnancy; Treatment Outcome	1999
Medical management of non-viable early first trimester pregnancy. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1999, Volume: 67, Issue:1 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Incomplete; Administration, Intravaginal; Drug Therapy, Combination; Female; Humans; Methotrexate; Misoprostol; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Treatment Outcome	1999
Randomized comparison of efficacy, acceptability and cost of medical versus surgical abortion. Contraception, 2000, Volume: 62, Issue:3 Topics: Abortifacient Agents; Abortion, Therapeutic; Adolescent; Adult; Female; Humans; Methotrexate; Misoprostol; Patient Acceptance of Health Care; Prospective Studies; Vacuum Curettage	2000
Misoprostol administration in medical abortion. A comparison of three regimens. The Journal of reproductive medicine, 2001, Volume: 46, Issue:2 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Methotrexate; Misoprostol; Tablets; Treatment Outcome	2001
Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol. Obstetrics and gynecology, 2002, Volume: 99, Issue:5 Pt 1 Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Hemorrhage; Humans; Methotrexate; Mifepristone; Misoprostol; Pain; Pregnancy	2002
Comparing vaginal and buccal misoprostol when used after methotrexate for early abortion. Contraception, 2004, Volume: 70, Issue:6 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Buccal; Administration, Intravaginal; Adult; Female; Gestational Age; Humans; Methotrexate; Misoprostol; Pregnancy; Treatment Outcome	2004
Evaluation of the efficacy of mifepristone/misoprostol and methotrexate/misoprostol for medical abortion. Indian journal of medical sciences, 2005, Volume: 59, Issue:7 Topics: Abortifacient Agents; Abortion, Induced; Adult; Chi-Square Distribution; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Treatment Outcome	2005
Methotrexate/misoprostol vs. a more standard approach for termination of pregnancies of undetermined location: a randomized, controlled trial. The Journal of reproductive medicine, 2005, Volume: 50, Issue:10 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Adult; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Pregnancy; Treatment Outcome	2005
Misoprostol alone vs. methotrexate followed by misoprostol for early abortion. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2006, Volume: 95, Issue:3 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Drug Combinations; Female; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Pregnancy	2006
Comparison of remote and in-clinic follow-up after methotrexate/misoprostol abortion. Contraception, 2015, Volume: 92, Issue:3 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Adult; Ambulatory Care Facilities; Canada; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Multivariate Analysis; Non-Randomized Controlled Trials as Topic; Patient Compliance; Pregnancy; Pregnancy Trimester, First; Telemedicine	2015

Other Studies

64 other study(ies) available for methotrexate and misoprostol

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Drug combination adds fuel to US abortion debate. BMJ (Clinical research ed.), 1995, Sep-16, Volume: 311, Issue:7007 Topics: Abortifacient Agents; Abortion, Induced; Attitude to Health; Drug Costs; Federal Government; Female; Government Regulation; Humans; Methotrexate; Misoprostol; Pregnancy; Pregnant Women; Risk Assessment; United States	1995
Methotrexate and misoprostol to terminate early pregnancy. The New England journal of medicine, 1995, Aug-31, Volume: 333, Issue:9 Topics: Abortion, Legal; Administration, Intravaginal; Adolescent; Adult; Female; Humans; Methotrexate; Middle Aged; Misoprostol; Pregnancy; Time Factors; Uterine Hemorrhage; Vacuum Curettage	1995
Non-surgical abortion: who's for methotrexate? Lancet (London, England), 1995, Sep-09, Volume: 346, Issue:8976 Topics: Abortifacient Agents; Abortion, Induced; Drug-Related Side Effects and Adverse Reactions; Federal Government; Female; Government; Government Regulation; Human Experimentation; Humans; Methods; Methotrexate; Mifepristone; Misoprostol; Pharmaceutical Preparations; Physicians; Pregnancy; Pregnant Women; Professional Competence; Risk; Risk Assessment; Social Control, Formal; United Kingdom; United States; United States Food and Drug Administration	1995
Methotrexate and misoprostol used in abortions. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1994, May-01, Volume: 150, Issue:9 Topics: Abortion, Induced; Female; Humans; Methotrexate; Misoprostol; Pilot Projects; Pregnancy	1994
Methotrexate and misoprostol used in abortions. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1994, Sep-01, Volume: 151, Issue:5 Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Methotrexate; Misoprostol; Pregnancy	1994
Methotrexate and misoprostol for early abortion. Contraception, 1993, Volume: 48, Issue:4 Topics: Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Female; Humans; Methotrexate; Misoprostol; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage	1993
Methotrexate and misoprostol to terminate early pregnancy. The New England journal of medicine, 1996, Feb-08, Volume: 334, Issue:6 Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy	1996
Methotrexate and misoprostol to terminate early pregnancy. The New England journal of medicine, 1996, Feb-08, Volume: 334, Issue:6 Topics: Abnormalities, Drug-Induced; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Methotrexate; Misoprostol; Pregnancy	1996
Methotrexate and misoprostol to terminate early pregnancy. The New England journal of medicine, 1996, Feb-08, Volume: 334, Issue:6 Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Neoplasms; Pregnancy	1996
Methotrexate and misoprostol to terminate early pregnancy. The New England journal of medicine, 1996, Feb-08, Volume: 334, Issue:6 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Ethics, Medical; Female; Humans; Methotrexate; Misoprostol; Pregnancy	1996
Abortion induced with methotrexate and misoprostol. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1996, Jan-15, Volume: 154, Issue:2 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Canada; Feasibility Studies; Female; Humans; Methotrexate; Middle Aged; Misoprostol; Pregnancy; Treatment Outcome	1996
Medical abortion: what does the research tell us? CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1996, Jan-15, Volume: 154, Issue:2 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Methotrexate; Misoprostol; Pregnancy; Teratogens; Treatment Failure	1996
[Methotrexate and misoprostol for drug-induced abortion in the first trimester]. Deutsche medizinische Wochenschrift (1946), 1995, Dec-22, Volume: 120, Issue:51-52 Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Methotrexate; Misoprostol; Pregnancy; Pregnancy Trimester, First; Time Factors	1995
Methotrexate and misoprostol when surgical abortion fails. Obstetrics and gynecology, 1996, Volume: 87, Issue:3 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Drug Therapy, Combination; Female; Folic Acid Antagonists; Humans; Methotrexate; Middle Aged; Misoprostol; Pregnancy; Treatment Failure; Vacuum Curettage	1996
Methotrexate and misoprostol for abortion. The Medical letter on drugs and therapeutics, 1996, Apr-26, Volume: 38, Issue:973 Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Female; Humans; Methotrexate; Misoprostol; Pregnancy; Pregnancy Trimester, First	1996
Combined methotrexate and misoprostol for early induced abortion. Archives of family medicine, 1996, Volume: 5, Issue:5 Topics: Abortion, Induced; Attitude of Health Personnel; Ethics, Medical; Family Practice; Female; Humans; Methotrexate; Misoprostol; Pregnancy; Publishing	1996
Combined methotrexate and misoprostol for early induced abortion. Archives of family medicine, 1996, Volume: 5, Issue:5 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Counseling; Ethics, Medical; Female; Humans; Methotrexate; Misoprostol; Pregnancy	1996
Combined methotrexate and misoprostol for early induced abortion. Archives of family medicine, 1996, Volume: 5, Issue:5 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Attitude of Health Personnel; Ethics, Medical; Family Practice; Female; Humans; Methotrexate; Misoprostol; Pregnancy	1996
Medically induced abortion in a woman with a large myomatous uterus. American journal of obstetrics and gynecology, 1996, Volume: 175, Issue:5 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Female; Humans; Leiomyoma; Methotrexate; Misoprostol; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Neoplasms	1996
Choosing between surgical abortions and medical abortions induced with methotrexate and misoprostol. Contraception, 1997, Volume: 55, Issue:2 Topics: Abortifacient Agents; Abortion, Induced; Adult; Age Factors; Analysis of Variance; British Columbia; Decision Making; Female; Gestational Age; Humans; Methotrexate; Misoprostol; Pregnancy; Racial Groups	1997
Effect of nonsteroidal anti-inflammatory drugs on the action of misoprostol in a regimen for early abortion. Contraception, 1997, Volume: 56, Issue:3 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Analgesia; Anti-Inflammatory Agents, Non-Steroidal; Drug Interactions; Female; Humans; Methotrexate; Misoprostol; Pregnancy; Uterine Contraction	1997
Toward safe and effective medical abortion. Science (New York, N.Y.), 1998, Jul-24, Volume: 281, Issue:5376 Topics: Abortifacient Agents; Abortion, Induced; Biomedical Research; Delivery of Health Care; Developing Countries; Female; Humans; Internationality; Legislation, Drug; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Risk Assessment; Therapeutic Human Experimentation; Women's Health	1998
Update on early medical and surgical abortion. Journal of women's health, 1998, Volume: 7, Issue:8 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Male; Methotrexate; Mifepristone; Misoprostol; Patient Selection; Pregnancy; Pregnancy Trimester, First; Vacuum Curettage	1998
Malignant trophoblastic disease following a twin pregnancy consisting of a complete hydatiform mole and a normal fetus and placenta. A case report. European journal of gynaecological oncology, 1999, Volume: 20, Issue:2 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Antimetabolites, Antineoplastic; Diagnosis, Differential; Female; Humans; Hydatidiform Mole, Invasive; Methotrexate; Misoprostol; Pregnancy; Pregnancy, Multiple; Trophoblastic Neoplasms; Twins; Uterine Neoplasms	1999
Conception rates after abortion with methotrexate and misoprostol. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1999, Volume: 65, Issue:2 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Adult; Cohort Studies; Female; Fertility; Follow-Up Studies; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Postoperative Period; Pregnancy	1999
Medical abortion alternatives to mifepristone. Journal of the American Medical Women's Association (1972), 2000, Volume: 55, Issue:3 Suppl Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Female; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Pregnancy; Research	2000
Research on regimens for early medical abortion. Journal of the American Medical Women's Association (1972), 2000, Volume: 55, Issue:3 Suppl Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Prostaglandins; Women's Health	2000
Instituting medical abortion services: changes in outcome and acceptability related to provider experience. Journal of the American Medical Women's Association (1972), 2000, Volume: 55, Issue:3 Suppl Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Female; Humans; Methotrexate; Middle Aged; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Vacuum Curettage	2000
Arteriovenous malformations of the uterus associated with medical abortion. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2000, Volume: 71, Issue:2 Topics: Abortion, Induced; Adult; Arteriovenous Malformations; Diagnosis, Differential; Female; Humans; Methotrexate; Misoprostol; Postoperative Complications; Pregnancy; Tamoxifen; Ultrasonography, Doppler; Uterine Hemorrhage; Uterus	2000
The second abortion pill. Scientific American, 2000, Volume: 283, Issue:6 Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Legal; Drug Approval; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; United States; United States Food and Drug Administration	2000
Early medical abortion with methotrexate and misoprostol. Obstetrics and gynecology, 2001, Volume: 97, Issue:1 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Female; Humans; Methotrexate; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Ultrasonography, Prenatal	2001
Early medical abortion with methotrexate and misoprostol. Obstetrics and gynecology, 2001, Volume: 97, Issue:5 Pt 1 Topics: Abortion, Therapeutic; Drug Therapy, Combination; Female; Humans; Methotrexate; Misoprostol; Patient Satisfaction; Pregnancy; Treatment Outcome	2001
Early medical abortion with methotrexate and misoprostol: outcomes and satisfaction among women aged 15-21 years. Journal of pediatric and adolescent gynecology, 2001, Volume: 14, Issue:1 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Female; Humans; Methotrexate; Misoprostol; Outcome Assessment, Health Care; Patient Satisfaction; Pregnancy; Prospective Studies	2001
ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Medical management of abortion. Obstetrics and gynecology, 2001, Volume: 97, Issue:4 Topics: Abortifacient Agents; Abortion, Induced; Counseling; Dilatation and Curettage; Drug Administration Schedule; Female; Gynecology; Humans; Methotrexate; Mifepristone; Misoprostol; Obstetrics; United States	2001
The abortion cocktail. First things (New York, N.Y.), 1996, Volume: 59 Topics: Abortion, Induced; Drug-Related Side Effects and Adverse Reactions; Ethics Committees; Ethics Committees, Research; Federal Government; Government; Government Regulation; Human Experimentation; Humans; Methotrexate; Mifepristone; Misoprostol; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Research Design; Research Personnel; Risk; Risk Assessment; Scientific Misconduct; Social Control, Formal	1996
Cervical pregnancy: two case reports. Connecticut medicine, 2002, Volume: 66, Issue:2 Topics: Abortifacient Agents, Nonsteroidal; Adult; Cervix Uteri; Female; Humans; Methotrexate; Misoprostol; Pregnancy; Pregnancy, Ectopic	2002
Fetal methotrexate and misoprostol exposure: the past revisited. Teratology, 2002, Volume: 66, Issue:2 Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Abortifacient Agents, Nonsteroidal; Abortion, Incomplete; Abortion, Induced; Adult; Female; Growth Disorders; Humans; Infant; Methotrexate; Misoprostol; Pregnancy	2002
Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion. American journal of obstetrics and gynecology, 2003, Volume: 188, Issue:3 Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Self Administration; Time Factors; Treatment Outcome	2003
Gestational trophoblastic tumor after medical abortion. Obstetrics and gynecology, 2003, Volume: 101, Issue:5 Pt 2 Topics: Abortifacient Agents, Steroidal; Abortion, Therapeutic; Adult; Antineoplastic Agents; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Mifepristone; Misoprostol; Oxytocics; Pregnancy; Pregnancy Trimester, First	2003
Early medical termination pregnancy with methotrexate and misoprostol in lower segment cesarean section cases. The journal of obstetrics and gynaecology research, 2003, Volume: 29, Issue:4 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Cesarean Section; Endpoint Determination; Female; Humans; Methotrexate; Misoprostol; Pregnancy; Prospective Studies	2003
Anomalies associated with failed methotrexate and misoprostol termination. Obstetrics and gynecology, 2005, Volume: 105, Issue:5 Pt 2 Topics: Abortion, Incomplete; Abortion, Induced; Adult; Congenital Abnormalities; Developmental Disabilities; Female; Fetus; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Methotrexate; Misoprostol; Pregnancy; Pregnancy Outcome; Risk Assessment; Ultrasonography, Prenatal	2005
[Medical abortion using methotrexate and misoprostol. Efficacy and tolerability]. Akusherstvo i ginekologiia, 2005, Volume: 44, Issue:3 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Drug Administration Schedule; Female; Humans; Methotrexate; Misoprostol; Pregnancy	2005
Providing medication abortion information to diverse communities: use patterns of a multilingual web site. Contraception, 2006, Volume: 74, Issue:3 Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Information Services; Internet; Language; Methotrexate; Mifepristone; Misoprostol; Pregnancy	2006
Failed methotrexate termination of pregnancy: a case report. Journal of perinatology : official journal of the California Perinatal Association, 2006, Volume: 26, Issue:10 Topics: Abnormalities, Multiple; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Female; Humans; Infant, Newborn; Male; Methotrexate; Misoprostol; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First	2006
Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions. BJOG : an international journal of obstetrics and gynaecology, 2007, Volume: 114, Issue:5 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Methotrexate; Misoprostol; Pregnancy; Retrospective Studies	2007
[Clinical value of transcervical resection under hysteroscope for placental remnants]. Zhonghua fu chan ke za zhi, 2007, Volume: 42, Issue:8 Topics: Abortifacient Agents, Nonsteroidal; Adult; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Electrosurgery; Female; Humans; Hysteroscopy; Methotrexate; Mifepristone; Misoprostol; Placenta, Retained; Pregnancy; Retrospective Studies; Treatment Outcome; Ultrasonography	2007
Comparison of four regimens of misoprostol after methotrexate for early abortion. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2008, Volume: 101, Issue:2 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Cohort Studies; Drug Administration Schedule; Female; Humans; Methotrexate; Middle Aged; Misoprostol; Pregnancy; Retrospective Studies	2008
[Good results of early medicinal pregnancy termination in a general practice on Curaçao]. Nederlands tijdschrift voor geneeskunde, 2008, Mar-01, Volume: 152, Issue:9 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Curettage; Female; Humans; Methotrexate; Middle Aged; Misoprostol; Netherlands Antilles; Pregnancy; Prospective Studies; Treatment Outcome	2008
Gestational trophoblastic tumor with liver metastasis after misoprostol abortion. Archives of gynecology and obstetrics, 2009, Volume: 279, Issue:4 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Liver Neoplasms; Methotrexate; Misoprostol; Pregnancy; Uterine Neoplasms; Vincristine	2009
Methotrexate with or without misoprostol to terminate pregnancies with no gestational sac visible by ultrasound. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2009, Volume: 107, Issue:1 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Gestational Age; Humans; Methotrexate; Misoprostol; Pregnancy; Ultrasonography, Prenatal; Young Adult	2009
First trimester bleeding. American family physician, 2009, Jun-01, Volume: 79, Issue:11 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Spontaneous; Chorionic Gonadotropin; Counseling; Diagnosis, Differential; Evidence-Based Medicine; Female; Gestational Trophoblastic Disease; Grief; Humans; Methotrexate; Misoprostol; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Pregnancy, Ectopic; Risk Factors; Ultrasonography, Prenatal; Uterine Hemorrhage	2009
[Unilateral odynophagia in rheumatoid arthritis]. Laryngo- rhino- otologie, 2011, Volume: 90, Issue:8 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cooperative Behavior; Deglutition Disorders; Diagnosis, Differential; Diclofenac; Drug Therapy, Combination; Dysphonia; Endoscopy; Female; Folic Acid; Humans; Interdisciplinary Communication; Lymphopenia; Methotrexate; Middle Aged; Misoprostol; Opportunistic Infections; Oral Ulcer; Pain; Pharyngitis; Prednisolone	2011
Methotrexate and misoprostol teratogenicity: further expansion of the clinical manifestations. American journal of medical genetics. Part A, 2011, Volume: 155A, Issue:7 Topics: Abnormalities, Drug-Induced; Abortifacient Agents; Fatal Outcome; Humans; Infant; Infant, Newborn; Male; Methotrexate; Misoprostol; Phenotype; Teratogens	2011
[Acute toxicity by methotrexate used for abortion purpose. Case report]. Ginecologia y obstetricia de Mexico, 2011, Volume: 79, Issue:1 Topics: Abortifacient Agents; Abortion, Induced; Abortion, Missed; Abortion, Septic; Administration, Intravaginal; Adolescent; Anti-Bacterial Agents; Antidotes; Candidiasis, Oral; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intramuscular; Leucovorin; Methotrexate; Misoprostol; Neutropenia; Poisoning; Pregnancy; Recombinant Proteins; Vomiting	2011
Medical termination of pregnancy in cynomolgus macaques. Journal of medical primatology, 2012, Volume: 41, Issue:6 Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Female; Gestational Age; Macaca fascicularis; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome	2012
New anomalies due to methotrexate and misoprostol exposure in early pregnancy. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2013, Volume: 122, Issue:3 Topics: Abnormalities, Multiple; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Female; Humans; Methotrexate; Misoprostol; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second	2013
[Again about the drug induced abortion]. Akusherstvo i ginekologiia, 2013, Volume: 52 Suppl 2 Topics: Abortifacient Agents; Abortion, Induced; Bulgaria; Female; Gestational Age; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy	2013
Use of telemedicine for providing medical abortion. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2014, Volume: 124, Issue:2 Topics: Abortifacient Agents; Abortion, Induced; Adult; British Columbia; Chorionic Gonadotropin; Female; Humans; Methotrexate; Misoprostol; Pregnancy; Retrospective Studies; Telemedicine	2014
Practice bulletin no. 143: medical management of first-trimester abortion. Obstetrics and gynecology, 2014, Volume: 123, Issue:3 Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Clinical Protocols; Directive Counseling; Drug Administration Schedule; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Patient Selection; Pregnancy; Pregnancy Trimester, First; Tamoxifen	2014
Limb anomalies, microcephaly, dysmorphic facial features and fibroma of the tongue after failed abortion with methotrexate and misoprostol. Clinical dysmorphology, 2020, Volume: 29, Issue:4 Topics: Abnormalities, Multiple; Abortion, Induced; Adult; Child, Preschool; Comparative Genomic Hybridization; Female; Fibroma; Genetic Testing; Humans; Limb Deformities, Congenital; Methotrexate; Microcephaly; Misoprostol; Musculoskeletal Abnormalities; Phenotype; Pregnancy	2020
Caesarean scar ectopic pregnancy: a case series and case report to highlight the experience in regional New Zealand. The New Zealand medical journal, 2021, 04-16, Volume: 134, Issue:1533 Topics: Abdominal Pain; Abortifacient Agents, Nonsteroidal; Adult; Cesarean Section; Cicatrix; Dilatation and Curettage; Female; Humans; Hysterectomy; Methotrexate; Misoprostol; Native Hawaiian or Other Pacific Islander; New Zealand; Pregnancy; Pregnancy, Ectopic; Retrospective Studies; Ultrasonography, Prenatal; Uterine Hemorrhage	2021
Fetal methotrexate syndrome following an unsuccessful medication abortion - a rare syndrome posed to become more common. Clinical dysmorphology, 2023, 07-01, Volume: 32, Issue:3 Topics: Abortion, Induced; Female; Fetus; Humans; Methotrexate; Misoprostol; Pregnancy; Syndrome	2023